These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3660066)

  • 1. Antibodies against Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in the intestinal fluid during convalescence.
    Chongsa-Nguan M; Chaicumpa W; Kalambaheti T; Surachedchai Y; Thanungkul B
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):33-8. PubMed ID: 3660066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vibriocidal antibody and antibodies to Vibrio cholerae lipopolysaccharide, cell-bound haemagglutinin and toxin in Thai population.
    Chongsa-nguan M; Chaicumpa W; Kalambaheti T; Soejoedi H; Luxananil P; Swasdikosa S; Thanasiri P; Mayurasakorn S
    Southeast Asian J Trop Med Public Health; 1986 Dec; 17(4):558-66. PubMed ID: 3576285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral vaccine against cholera prepared from Vibrio cholerae antigen(s).
    Chaicumpa W; Chaisri U; Tapchaisri P; Chongsa-Nguan M; Pongponratn E
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):142-8. PubMed ID: 3313733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-bound haemagglutinin (CHA) of V. cholerae 01 as protective antigen.
    Chaicumpa W; Boonthum A; Kalumbaheti T; Tapchaisri P
    Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):407-13. PubMed ID: 6523176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cholera in breast-fed children by antibodies in breast milk.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Hossain KM; Huq MI; Holmgren J
    N Engl J Med; 1983 Jun; 308(23):1389-92. PubMed ID: 6843632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of soluble haemagglutinin-lipopolysaccharide complex of classical vibrio cholerae.
    Chaicumpa W; Swasdikosa S
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):548-58. PubMed ID: 6673133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
    Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The study of intestinal immunity against V. cholerae: purification of V. cholerae El Tor haemagglutinin and the protective role of its antibody in experimental cholera.
    Chaicumpa W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1979 Mar; 10(1):73-80. PubMed ID: 483020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity.
    Chaicumpa W; Atthasisiha N
    Southeast Asian J Trop Med Public Health; 1977 Mar; 8(1):13-8. PubMed ID: 887992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Vibrio cholerae toxoid on the levels of antibodies of the IgG, IgA and IgM classes in rabbits].
    Aleksandrowicz J; Kudelski Z
    Med Dosw Mikrobiol; 1986; 38(1):15-22. PubMed ID: 3713366
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenicity of two formulations of oral cholera vaccines in Thai volunteers.
    Chongsa-nguan M; Chaicumpa W; Ruangkunaporn Y; Looareesuwan S
    Vaccine; 1991 Jan; 9(1):53-9. PubMed ID: 2008802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific antibodies to cholera toxin in rabbit milk are protective against Vibrio cholerae-induced intestinal secretion.
    Yoshiyama Y; Brown WR
    Immunology; 1987 Aug; 61(4):543-7. PubMed ID: 3443455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
    Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
    Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of J chain inhibits the transport of gut IgA and abrogates the development of intestinal antitoxic protection.
    Lycke N; Erlandsson L; Ekman L; Schön K; Leanderson T
    J Immunol; 1999 Jul; 163(2):913-9. PubMed ID: 10395687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.